Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either acute or chronic infections.
The report details the trend, potential and market size of Hepatitis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hepatitis Drugsmarket, defines the market attractiveness level of Hepatitis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hepatitis Drugs industry, describes the types of Hepatitis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hepatitis Drugs market and the development prospects and opportunities of Hepatitis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hepatitis Drugs market in Chapter 13.
By Player:
Vertex Pharmaceuticals
Achillion Pharmaceuticals
Gilead Sciences
Novartis
Johnson & Johnson
GlaxoSmithKline
Merck
Bristol-Myers Squibb
Abbvie
By Type:
VEMLIDY
EPCLUSA
SOVALDI
INCIVEK
OLYSIO
VICTRELIS
VIREAD
HEPSERA
BARACLUDE
TYZEKA
By End-User:
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hepatitis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hepatitis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hepatitis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hepatitis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hepatitis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Hepatitis Drugs Consumption (2017-2022)
-
7.2 United States Hepatitis Drugs Consumption (2017-2022)
-
7.3 Europe Hepatitis Drugs Consumption (2017-2022)
-
7.4 China Hepatitis Drugs Consumption (2017-2022)
-
7.5 Japan Hepatitis Drugs Consumption (2017-2022)
-
7.6 India Hepatitis Drugs Consumption (2017-2022)
-
7.7 South Korea Hepatitis Drugs Consumption (2017-2022)
8 Region and Country-wise Hepatitis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Hepatitis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Hepatitis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Hepatitis Drugs Consumption Forecast (2022-2028)
-
8.4 China Hepatitis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Hepatitis Drugs Consumption Forecast (2022-2028)
-
8.6 India Hepatitis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Hepatitis Drugs Consumption Forecast (2022-2028)
9 Global Hepatitis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Hepatitis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global VEMLIDY Consumption and Growth Rate (2017-2022)
-
9.1.2 Global EPCLUSA Consumption and Growth Rate (2017-2022)
-
9.1.3 Global SOVALDI Consumption and Growth Rate (2017-2022)
-
9.1.4 Global INCIVEK Consumption and Growth Rate (2017-2022)
-
9.1.5 Global OLYSIO Consumption and Growth Rate (2017-2022)
-
9.1.6 Global VICTRELIS Consumption and Growth Rate (2017-2022)
-
9.1.7 Global VIREAD Consumption and Growth Rate (2017-2022)
-
9.1.8 Global HEPSERA Consumption and Growth Rate (2017-2022)
-
9.1.9 Global BARACLUDE Consumption and Growth Rate (2017-2022)
-
9.1.10 Global TYZEKA Consumption and Growth Rate (2017-2022)
-
9.2 Global Hepatitis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hepatitis A Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hepatitis C Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Hepatitis D Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Hepatitis E Consumption and Growth Rate (2017-2022)
10 Global Hepatitis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Hepatitis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global VEMLIDY Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global EPCLUSA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global SOVALDI Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global INCIVEK Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global OLYSIO Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global VICTRELIS Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global VIREAD Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global HEPSERA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global BARACLUDE Consumption Forecast and Growth Rate (2022-2028)
-
10.1.10 Global TYZEKA Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hepatitis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hepatitis A Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hepatitis C Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Hepatitis D Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Hepatitis E Consumption Forecast and Growth Rate (2022-2028)
11 Global Hepatitis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hepatitis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hepatitis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hepatitis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hepatitis Drugs Market Competitive Analysis
-
14.1 Vertex Pharmaceuticals
-
14.1.1 Vertex Pharmaceuticals Company Details
-
14.1.2 Vertex Pharmaceuticals Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Vertex Pharmaceuticals Hepatitis Drugs Product and Service
-
14.2 Achillion Pharmaceuticals
-
14.2.1 Achillion Pharmaceuticals Company Details
-
14.2.2 Achillion Pharmaceuticals Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Achillion Pharmaceuticals Hepatitis Drugs Product and Service
-
14.3 Gilead Sciences
-
14.3.1 Gilead Sciences Company Details
-
14.3.2 Gilead Sciences Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Gilead Sciences Hepatitis Drugs Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Hepatitis Drugs Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Hepatitis Drugs Product and Service
-
14.6 GlaxoSmithKline
-
14.6.1 GlaxoSmithKline Company Details
-
14.6.2 GlaxoSmithKline Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline Hepatitis Drugs Product and Service
-
14.7 Merck
-
14.7.1 Merck Company Details
-
14.7.2 Merck Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck Hepatitis Drugs Product and Service
-
14.8 Bristol-Myers Squibb
-
14.8.1 Bristol-Myers Squibb Company Details
-
14.8.2 Bristol-Myers Squibb Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bristol-Myers Squibb Hepatitis Drugs Product and Service
-
14.9 Abbvie
-
14.9.1 Abbvie Company Details
-
14.9.2 Abbvie Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Abbvie Hepatitis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hepatitis Drugs
-
Figure Hepatitis Drugs Picture
-
Table Global Hepatitis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatitis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatitis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hepatitis Drugs Consumption by Country (2017-2022)
-
Figure United States Hepatitis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Hepatitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Hepatitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Hepatitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Hepatitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hepatitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Hepatitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hepatitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hepatitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hepatitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hepatitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hepatitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VEMLIDY Consumption and Growth Rate (2017-2022)
-
Figure Global EPCLUSA Consumption and Growth Rate (2017-2022)
-
Figure Global SOVALDI Consumption and Growth Rate (2017-2022)
-
Figure Global INCIVEK Consumption and Growth Rate (2017-2022)
-
Figure Global OLYSIO Consumption and Growth Rate (2017-2022)
-
Figure Global VICTRELIS Consumption and Growth Rate (2017-2022)
-
Figure Global VIREAD Consumption and Growth Rate (2017-2022)
-
Figure Global HEPSERA Consumption and Growth Rate (2017-2022)
-
Figure Global BARACLUDE Consumption and Growth Rate (2017-2022)
-
Figure Global TYZEKA Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis A Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis C Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis D Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis E Consumption and Growth Rate (2017-2022)
-
Figure Global VEMLIDY Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global EPCLUSA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global SOVALDI Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global INCIVEK Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OLYSIO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VICTRELIS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VIREAD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HEPSERA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BARACLUDE Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TYZEKA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis C Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis D Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis E Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hepatitis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hepatitis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Vertex Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Vertex Pharmaceuticals Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Pharmaceuticals Hepatitis Drugs Product and Service
-
Table Achillion Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Achillion Pharmaceuticals Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Achillion Pharmaceuticals Hepatitis Drugs Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Hepatitis Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Hepatitis Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Hepatitis Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Hepatitis Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Hepatitis Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Hepatitis Drugs Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Hepatitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Hepatitis Drugs Product and Service
-
